Contact
searchSearch
HMP Global

Acne Excellence Forum

Featured

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
acne on face of an adolescent
Quiz
Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
young woman applies acne cream on female face with pimples
Quiz
Insights: Clascoterone Cream 1%
11/06/2025
Jessica Garlewicz
According to Dr Mark Lebwohl’s Fall Clinical 2025 presentation, which of the following statements about clascoterone cream 1% is correct?
According to Dr Mark Lebwohl’s Fall Clinical 2025 presentation, which of the following statements about clascoterone cream 1% is correct?
According to Dr Mark Lebwohl’s...
11/06/2025
The Dermatologist
Mark Lebwohl, MD, headshot
Conference Coverage
Optimizing Acne Management With Durable Topical and Oral Therapies
10/28/2025
Jessica Garlewicz
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025...
10/28/2025
The Dermatologist
Hilary Baldwin, MD
Conference Coverage
Advances in Topical Acne Treatments: Balancing Efficacy with Patient Safety
10/13/2025
Jessica Garlewicz
During Dermatology Week, Steven Feldman, MD, PhD, was joined by Hilary Baldwin, MD; Ruth Ann Vleugels, MD, MPH, MBA; and Vincent Richer, MD, FRCPC, to discuss advances and considerations in topical acne treatments.
During Dermatology Week, Steven Feldman, MD, PhD, was joined by Hilary Baldwin, MD; Ruth Ann Vleugels, MD, MPH, MBA; and Vincent Richer, MD, FRCPC, to discuss advances and considerations in topical acne treatments.
During Dermatology Week, Steven...
10/13/2025
The Dermatologist
Wooden-blocks-that-spell-quiz
Quiz
Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
Shanna Miranti
Conference Coverage
Latest Acne and Rosacea Therapies Unveiled at Dermatology Week
05/14/2025
Riya Gandhi, MA
Shannon Maranti shared practical updates on targeted acne regimens and rosacea phenotyping—spotlighting the new triple combination topical treatment and insights on personalized care.
Shannon Maranti shared practical updates on targeted acne regimens and rosacea phenotyping—spotlighting the new triple combination topical treatment and insights on personalized care.
Shannon Maranti shared practical...
05/14/2025
The Dermatologist
Clinical Insights
Treating Acne Sequelae
09/06/2024
Riya Gandhi, MA
There are many new devices available to target the aftereffects of acne, allowing dermatologists to tailor treatment plans for the best possible patient outcomes.
There are many new devices available to target the aftereffects of acne, allowing dermatologists to tailor treatment plans for the best possible patient outcomes.
There are many new devices...
09/06/2024
The Dermatologist
Dr Jenna Lester
Podcasts
Acne Impact on Patients With Skin of Color
03/21/2022
Jenna Lester, MD, FAAD
Dr Jenna Lester shares the treatment disparities, pigmentary complications, and more on how acne impacts patients with skin of color.
Dr Jenna Lester shares the treatment disparities, pigmentary complications, and more on how acne impacts patients with skin of color.
Dr Jenna Lester shares the...
03/21/2022
The Dermatologist
Seemal Desai, MD, FAAD
Videos
Insights From AAD: Acne and Dyspigmentation
02/24/2022
Seemal R. Desai, MD, FAAD
Dr Seemal Desai gives a sneak peek into his sessions on acne and dyspigmentation alongside his hopes for the 2022 AAD Annual Meeting.
Dr Seemal Desai gives a sneak peek into his sessions on acne and dyspigmentation alongside his hopes for the 2022 AAD Annual Meeting.
Dr Seemal Desai gives a sneak...
02/24/2022
The Dermatologist
Dr Steve Feldman
Commentary
Eye of the Beholder: iPLEDGE and Acne Treatments
12/28/2021
Steven R. Feldman, MD, PhD; Patrick O. Perche, BS; Madison K. Cook, BS
Isotretinoin access may currently be complicated by iPLEDGE issues, but dermatologists have another tool in their arsenal to help patients with severe acne.
Isotretinoin access may currently be complicated by iPLEDGE issues, but dermatologists have another tool in their arsenal to help patients with severe acne.
Isotretinoin access may...
12/28/2021
The Dermatologist

Expert Insights

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
Seemal Desai, MD, FAAD
Videos
Insights From AAD: Acne and Dyspigmentation
02/24/2022
Seemal R. Desai, MD, FAAD
Dr Seemal Desai gives a sneak peek into his sessions on acne and dyspigmentation alongside his hopes for the 2022 AAD Annual Meeting.
Dr Seemal Desai gives a sneak peek into his sessions on acne and dyspigmentation alongside his hopes for the 2022 AAD Annual Meeting.
Dr Seemal Desai gives a sneak...
02/24/2022
The Dermatologist
Videos
Beneath the Mask: Treating “Maskne”
12/18/2020
Julie C. Harper, MD, discusses some of the latest trends in social media for the prevention of maskne as well as reviews treatment options for patients with acne.
Julie C. Harper, MD, discusses some of the latest trends in social media for the prevention of maskne as well as reviews treatment options for patients with acne.
Julie C. Harper, MD, discusses...
12/18/2020
The Dermatologist
Videos
Acne and Psychosocial Burden in LGBTQ Patients
08/25/2020
Angelo Landriscina, MD, reviewed important considerations dermatologists should keep in mind when treating LGBTQ patients with acne, such as discrimination and screening for psychological comorbidities.
Angelo Landriscina, MD, reviewed important considerations dermatologists should keep in mind when treating LGBTQ patients with acne, such as discrimination and screening for psychological comorbidities.
Angelo Landriscina, MD, reviewed...
08/25/2020
The Dermatologist
Videos
Treating Acne in LGBTQ Patients
08/25/2020
Angelo Landriscina, MD, discusses treatment considerations for the management of acne in LGTBQ patients, including iPLEDGE.
Angelo Landriscina, MD, discusses treatment considerations for the management of acne in LGTBQ patients, including iPLEDGE.
Angelo Landriscina, MD,...
08/25/2020
The Dermatologist
Dr Lisa Swanson
Videos
Pediatric Atopic Dermatitis: Diagnosis, Treatment Selection, and Long-Term Health Considerations
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
KOL Roundtable
Videos
Type 2 Inflammation as an Underlying Disease Driver
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist
Brian Kim
Videos
From Cytokines to Clinic: Translating Type 2 Biology Into Prurigo Nodularis Treatment
11/01/2026
Brian Kim, MD, MTR, FAAD; Riya Gandhi, MA
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4...
11/01/2026
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist

Popular Articles

Depressed-woman-sitting-on-edge-of-bed
Quiz
Acne and Depressive Symptoms
02/07/2025
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental...
02/07/2025
The Dermatologist
Jeffrey M. Cohen, MD
Conference Coverage
TYK2 as a Therapeutic Target in Psoriasis
08/11/2025
Coleen Stern, MA
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed...
08/11/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
Riya Gandhi, MA
What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?
What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?
What alternative therapies does...
11/11/2024
The Dermatologist
Melissa Mauskar, MD
Conference Coverage
Managing Complex and Sensitive Genital Dermatologic Conditions: A Patient-Centered Approach
11/15/2024
Jessica Garlewicz
During the second day of Fall Dermatology Week, Melissa Mauskar, MD, shared insights on treating patients with genital dermatologic conditions, emphasizing the complexity and sensitivity of this patient population.
During the second day of Fall Dermatology Week, Melissa Mauskar, MD, shared insights on treating patients with genital dermatologic conditions, emphasizing the complexity and sensitivity of this patient population.
During the second day of Fall...
11/15/2024
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use